What are the indications of the COZING-USBN4 nasal laser treatment?
- Alleviating nasal symptomology
- Chronic rhinitis
- Sinus headache
- Postnasal drip
- Sinus pressure or discomfort
- Improving nose blood circulation
What's the technical parameter of the COZING-USBN4 nasal laser treatment ?
|
Model Number |
COZING-USBN4 |
|
Instrument classification |
Class II |
|
Product name |
laser rhinitis treatment |
|
Wavelength |
650nm laser |
|
Power supply |
power bank, computer, phone charger, etc. |
|
Certificate |
CE |
|
Design |
humanized |
What are the advantages of the COZING-USBN4 nasal laser treatment ?
1. Designed with a USB interface, allowing it to function independently without needing to connect to the primary unit. It can also connect to a computer, power bank, or adapter for operation.
2. COZING-USBN effectively addresses conditions like Chronic rhinitis,Postnasal drip and helps alleviate recurring symptoms.
3.Ease of use.
4. Its small and lightweight design makes it highly portable.
5. Just plug it in, and the laser output starts automatically.
How does the COZING-USBN4 nasal laser treatment work ?
Low-level nasal laser treatment, also known as low-level laser therapy (LLLT) for nasal conditions.
Low-level laser light is emitted into the nasal passages, where it penetrates the tissues and interacts with cellular components. This interaction can help reduce inflammation by modulating inflammatory mediators, such as cytokines. By decreasing inflammation, it can alleviate symptoms such as nasal congestion, nasal discharge, and facial pain associated with conditions like rhinitis and sinusitis.
Low-level nasal laser treatment stimulates microcirculation in the nasal mucosa and sinus tissues. This increased blood flow helps deliver oxygen and nutrients to the affected areas while removing waste products and toxins. Improved circulation can accelerate tissue healing, reduce swelling, and promote overall nasal health.And Cozing-USBN has analgesic effects, meaning it can help alleviate pain associated with nasal conditions. By stimulating the release of endorphins and blocking pain signals, LLLT can provide relief from headaches, facial pain, and sinus pressure.
COZING-USBN4 nasal laser treatment Display:
COZING-USBN4 nasal laser treatment Clinical study:
Abstract: Allergic rhinitis (AR) is a prevalent condition that affects both social and physical functioning, diminishing quality of life. Symptoms include sneezing, rhinorrhea, nasal congestion, and itching, which often respond poorly to conventional drug treatments. Low-level laser therapy (LLLT) has shown anti-inflammatory and immunosuppressive effects in some studies. This study aims to systematically review and meta-analyze the effectiveness of LLLT in treating AR.
Methods: A comprehensive search of PubMed, Scopus, and Web of Science was performed on November 24, 2023. Studies examining the impact of LLLT on AR were included. A pre-post meta-analysis was conducted on nasal symptoms (rhinorrhea, nasal congestion, itching, and sneezing) in patients treated with LLLT. Additionally, Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores were analyzed before and after LLLT, along with a pairwise meta-analysis comparing LLLT to placebo, acupuncture, steroids/antihistamines, and ultraviolet lasers. A random-effects model was applied, using a conservative pre-post correlation of 0.4 and standardized mean difference (SMD) as the effect size.
Results:Sixteen studies met the inclusion criteria. LLLT significantly alleviated nasal symptoms in AR patients (SMD: -1.4, 95% CI: [-2.07 to -1.13], p < 0.001). RQLQ scores also showed a reduction after LLLT (SMD = -0.72, 95% CI: [-0.94 to -0.50], p < 0.001), with minimal adverse events reported. However, the meta-analysis revealed significant publication bias and heterogeneity. Compared to placebo, LLLT did not show a significant improvement in nasal symptoms (SMD: -0.69, p = 0.167), suggesting that the observed benefits may be due to a placebo effect. Insufficient data limited meaningful comparisons with other treatments, though LLLT appeared less effective than UV lasers.
Conclusion:LLLT likely reduces nasal symptoms with a low incidence of adverse events, but further high-quality studies with larger sample sizes are needed to confirm its effectiveness over placebo and to compare it with standard treatments in non-inferiority trials.
FAQ
